Revaiv

Main information

  • Trade name:
  • Revaiv 1mg/ mL Concentrate for Solution for IV Infusion
  • Dosage:
  • 1mg/ mL
  • Pharmaceutical form:
  • Concentrate for Solution for IV Infusion
  • Units in package:
  • USP type I glass ampoule x 2mL (Box of 5 blister pack x 5's)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Harson Laboratories

Documents

Localization

  • Available in:
  • Revaiv 1mg/ mL Concentrate for Solution for IV Infusion
    Philippines
  • Language:
  • English

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DRP-7362
  • Authorization date:
  • 09-10-2022
  • Last update:
  • 07-04-2018